PROF

Profound Medical Corp.

Price Chart

Latest Quote

$6.87

+0.30 (+4.57%)

Current Price

Previous Close	$6.57
Open	$6.60
Day High	$6.89
Day Low	$6.59
Volume	88,507

Fetched: 2026-06-22T09:06:55

Stock Information

Shares Outstanding	36.34M
Total Debt	$7.46M
Cash Equivalents	$50.30M
Revenue	$18.81M
Net Income	$-38.90M
Sector	Healthcare
Industry	Medical Devices
Market Cap	$249.64M
EPS (TTM)	$-1.24
Exchange	NCM

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$206.81M
Sales	$18.81M
Income	$-38.90M
Book/sh	$1.64
Cash/sh	$1.38
Employees	162

Financial Ratios

Quick Ratio	5.63
Current Ratio	6.55
Debt/Eq	12.56

Returns & Margins

ROA	-35.47%
ROE	-70.59%
Gross Margin	71.08%
Operating Margin	-150.29%
Profit Margin	-206.76%

Ownership

Insider Ownership	4.07%
Institutional Ownership	47.96%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	-9.14
P/S	13.27
P/B	4.20

Analyst Data

Recommendation	none
Target Price	$11.14

Technical Indicators

SMA20	$6.73
SMA50	$6.77
SMA200	$6.46
RSI	51.60
ATR	0.3206

Shares Float	34.74M
Short Float	6.87%
Short Ratio	31.17
Volatility	0.52
Rel Volume	1.44

Performance History

Week	+3.31%
Month	+2.08%
Quarter	+33.14%
6 Months	-9.01%
YTD	-10.31%
Year	+1.18%
3 Years	-51.99%
5 Years	-63.39%
10 Years	-29.23%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-18	$6.87	88,500
2026-06-17	$6.57	91,700
2026-06-16	$6.73	109,800
2026-06-15	$6.71	70,000
2026-06-12	$6.62	4,900
2026-06-11	$6.65	33,400
2026-06-10	$6.71	20,200
2026-06-09	$6.82	60,800
2026-06-08	$6.57	16,500
2026-06-05	$6.66	107,700
2026-06-04	$6.79	111,600
2026-06-03	$6.55	39,900
2026-06-02	$6.48	94,900
2026-06-01	$6.67	55,400
2026-05-29	$6.81	28,300
2026-05-28	$6.90	30,100
2026-05-27	$6.87	45,300
2026-05-26	$6.77	135,000
2026-05-22	$6.83	31,900
2026-05-21	$6.97	49,700
2026-05-20	$6.92	66,600
2026-05-19	$6.73	38,500

About Profound Medical Corp.

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

📰 Latest News

Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?

Zacks • 2026-05-18T13:55:02Z

Profound Medical Q1 Earnings Call Highlights

MarketBeat • 2026-05-08T21:07:42Z

Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates

Zacks • 2026-05-07T21:55:07Z

Profound Medical Down 8.5% After Hours as Its Q1 Loss Narrows, Revenue More Than Doubles, Beats Estimates

MT Newswires • 2026-05-07T20:41:31Z

Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near Future

Simply Wall St. • 2026-05-03T12:04:01Z

Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates

Zacks • 2026-04-30T12:30:08Z

Profound Medical Showcases TULSA Data, AI Software Upgrades, and Reimbursement Tailwinds at Conference

MarketBeat • 2026-04-25T20:02:11Z

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

Zacks • 2026-03-26T13:25:00Z

Profound Medical reports CAPTAIN trial meets primary safety endpoint

TipRanks • 2026-03-14T14:40:28Z

Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic ...

GuruFocus.com • 2026-03-06T05:02:23Z

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$4,705,000	$3,643,000	$2,887,000	$3,660,000
Cost Of Revenue	$4,705,000	$3,643,000	$2,887,000	$3,660,000
Total Revenue	$16,098,000	$10,680,000	$7,199,000	$6,681,000
Operating Revenue	$16,098,000	$10,680,000	$7,199,000	$6,681,000
Expenses
Total Expenses	$57,352,000	$43,742,000	$35,850,000	$36,283,000
Other Income Expense	$-2,134,000	$3,808,000	$-575,000	$301,000
Net Non Operating Interest Income Expense	$1,070,000	$1,436,000	$775,000	$919,000
Total Other Finance Cost	$-1,070,000	$-1,436,000	$-775,000	$-290,000
Operating Expense	$52,647,000	$40,099,000	$32,963,000	$32,623,000
Interest Expense	-	-	$770,000	$174,000
Rent Expense Supplemental	-	-	$715,000	$496,000
Interest Expense Non Operating	-	-	$770,000	$174,000
Selling And Marketing Expense	-	-	$9,453,000	$8,468,000
General And Administrative Expense	-	-	$9,168,000	$9,465,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Net Interest Income	$1,070,000	$1,436,000	$775,000	$919,000
Normalized Income	$-40,756,100	$-31,623,726	$-27,750,587	$-28,891,108
Net Income From Continuing And Discontinued Operation	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Total Operating Income As Reported	$-41,254,000	$-33,062,000	$-28,651,000	$-32,126,000
Net Income Common Stockholders	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Net Income	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Net Income Including Noncontrolling Interests	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Net Income Continuous Operations	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Pretax Income	$-42,318,000	$-27,818,000	$-28,451,000	$-28,382,000
Operating Income	$-41,254,000	$-33,062,000	$-28,651,000	$-29,602,000
Gross Profit	$11,393,000	$7,037,000	$4,312,000	$3,021,000
Interest Income	-	-	$1,642,000	$803,000
Special Income Charges	-	-	$0	$-2,524,000
Interest Income Non Operating	-	-	$1,642,000	$803,000
Per Share
Diluted EPS	$-1.41	$-1.12	$-1.34	$-1.38
Basic EPS	$-1.41	$-1.12	$-1.34	$-1.38
Other
Tax Effect Of Unusual Items	$-320,100	$274	$-2,587	$78,892
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-38,560,000	$-35,934,000	$-27,147,000	$-26,905,000
Total Unusual Items	$-2,134,000	$3,808,000	$-575,000	$301,000
Total Unusual Items Excluding Goodwill	$-2,134,000	$3,808,000	$-575,000	$301,000
Reconciled Depreciation	$560,000	$936,000	$929,000	$1,604,000
EBITDA (Bullshit earnings)	$-40,694,000	$-32,126,000	$-27,722,000	$-26,604,000
EBIT	$-41,254,000	$-33,062,000	$-28,651,000	$-28,208,000
Diluted Average Shares	$30,232,966	$24,765,503	$21,182,558	$20,774,638
Basic Average Shares	$30,232,966	$24,765,503	$21,182,558	$20,774,638
Diluted NI Availto Com Stockholders	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Tax Provision	$252,000	$-2,000	$-128,000	$287,000
Gain On Sale Of Security	$-2,134,000	$3,808,000	$-575,000	$2,825,000
Research And Development	$20,596,000	$16,965,000	$14,424,000	$14,690,000
Selling General And Administration	$32,051,000	$23,134,000	$18,539,000	$17,933,000
Impairment Of Capital Assets	-	-	$0	$2,524,000
Other Gand A	-	-	$9,168,000	$9,465,000
Restructuring And Mergern Acquisition	-	-	-	-

Fetched: 2026-06-17

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$66,296,000	$60,161,000	$30,734,000	$51,324,000
Total Assets	$77,475,000	$70,234,000	$43,956,000	$64,421,000
Total Non Current Assets	$1,386,000	$1,169,010	$2,060,000	$2,397,000
Non Current Deferred Assets	$66,000	$87,000	$0	-
Non Current Deferred Taxes Assets	$66,000	$87,000	$0	-
Non Current Accounts Receivable	$300,000	-	-	-
Goodwill And Other Intangible Assets	$138,000	$261,000	$490,000	$680,000
Other Intangible Assets	$138,000	$261,000	$490,000	$680,000
Current Assets	$76,089,000	$69,065,000	$41,896,000	$62,024,000
Prepaid Assets	$928,000	$1,307,000	$1,406,000	$1,222,000
Inventory	$8,238,000	$5,801,000	$6,989,000	$7,941,000
Receivables	$7,200,000	$7,045,000	$7,288,000	$6,344,000
Accounts Receivable	$7,200,000	$6,585,000	$7,145,000	$5,980,000
Cash Cash Equivalents And Short Term Investments	$59,723,000	$54,912,000	$26,213,000	$46,517,000
Cash And Cash Equivalents	$59,723,000	$54,912,000	$26,213,000	$46,517,000
Cash Financial	$59,723,000	$54,912,000	$26,213,000	$46,517,000
Receivables Adjustments Allowances	-	$-158,000	$-391,000	$-143,000
Other Receivables	-	$310,000	$120,000	$13,000
Taxes Receivable	-	$308,000	$414,000	$494,000
Allowance For Doubtful Accounts Receivable	-	$-158,000	$-391,000	$-143,000
Gross Accounts Receivable	-	$6,585,000	$7,145,000	$5,980,000
Debt
Total Debt	$4,712,000	$5,121,000	$7,867,000	$8,230,000
Long Term Debt And Capital Lease Obligation	$4,499,000	$3,127,000	$5,504,000	$7,468,000
Long Term Debt	$4,499,000	$2,924,000	$5,000,000	$6,651,000
Current Debt And Capital Lease Obligation	$213,000	$1,994,000	$2,363,000	$762,000
Current Debt	-	$1,737,000	$2,104,000	$523,000
Other Current Borrowings	-	$1,737,000	$2,104,000	$523,000
Liabilities
Total Liabilities Net Minority Interest	$11,041,000	$9,812,000	$12,732,000	$12,417,000
Total Non Current Liabilities Net Minority Interest	$4,966,000	$3,247,000	$6,364,000	$8,232,000
Other Non Current Liabilities	$79,000	$71,000	$73,000	-
Non Current Deferred Liabilities	$388,000	$49,000	$787,000	$764,000
Current Liabilities	$6,075,000	$6,565,000	$6,368,000	$4,185,000
Other Current Liabilities	$524,000	$325,000	$663,000	$563,000
Current Deferred Liabilities	$445,000	$419,000	$721,000	$471,000
Payables And Accrued Expenses	$2,546,000	$3,121,000	$1,869,000	$2,331,000
Payables	$1,602,000	$1,317,000	$865,000	$2,331,000
Total Tax Payable	$39,000	$0	$0	$298,000
Income Tax Payable	$39,000	$0	$0	$298,000
Accounts Payable	$1,563,000	$1,317,000	$865,000	$2,033,000
Non Current Deferred Taxes Liabilities	-	$0	$59,000	$0
Equity
Common Stock Equity	$66,434,000	$60,422,000	$31,224,000	$52,004,000
Total Equity Gross Minority Interest	$66,434,000	$60,422,000	$31,224,000	$52,004,000
Stockholders Equity	$66,434,000	$60,422,000	$31,224,000	$52,004,000
Gains Losses Not Affecting Retained Earnings	$5,025,000	$2,742,000	$5,565,000	$16,837,000
Other Equity Adjustments	$5,025,000	$2,742,000	$5,565,000	$16,837,000
Retained Earnings	$-287,740,000	$-245,170,000	$-217,354,000	$-189,362,000
Other
Ordinary Shares Number	$36,293,640	$30,039,809	$21,370,565	$20,879,497
Share Issued	$36,293,640	$30,039,809	$21,370,565	$20,879,497
Tangible Book Value	$66,296,000	$60,161,000	$30,734,000	$51,324,000
Invested Capital	$70,933,000	$65,083,000	$38,328,000	$59,178,000
Working Capital	$70,014,000	$62,500,000	$35,528,000	$57,839,000
Capital Lease Obligations	$213,000	$460,000	$763,000	$1,056,000
Total Capitalization	$70,933,000	$63,346,000	$36,224,000	$58,655,000
Additional Paid In Capital	$25,310,000	$21,298,000	$20,808,000	$18,704,000
Capital Stock	$323,839,000	$281,552,000	$222,205,000	$205,825,000
Common Stock	$323,839,000	$281,552,000	$222,205,000	$205,825,000
Non Current Deferred Revenue	$388,000	$49,000	$728,000	$764,000
Long Term Capital Lease Obligation	$0	$203,000	$504,000	$817,000
Current Deferred Revenue	$445,000	$419,000	$721,000	$471,000
Current Capital Lease Obligation	$213,000	$257,000	$259,000	$239,000
Pensionand Other Post Retirement Benefit Plans Current	$2,347,000	$706,000	$752,000	-
Current Accrued Expenses	$944,000	$1,804,000	$1,004,000	-
Net PPE	$882,000	$821,010	$1,570,000	$1,717,000
Accumulated Depreciation	$-1,591,000	$-2,389,990	$-2,216,000	$-2,339,000
Gross PPE	$2,473,000	$3,211,000	$3,786,000	$4,056,000
Leases	$542,000	$542,000	$542,000	$2,221,000
Other Properties	$1,931,000	$2,669,000	$3,244,000	$1,835,000
Properties	$0	$0	$0	$0
Finished Goods	$5,280,000	$3,837,000	$4,638,000	$5,455,000
Raw Materials	$2,958,000	$1,964,000	$2,351,000	$2,491,000
Inventories Adjustments Allowances	-	-	$-8,000	$-5,000
Current Provisions	-	-	-	$58,000
Goodwill	-	-	-	$0
Machinery Furniture Equipment	-	-	-	$0

Fetched: 2026-06-17

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-38,449,000	$-23,453,000	$-22,609,000	$-25,800,000
Operating Activities
Operating Cash Flow	$-38,207,000	$-23,453,000	$-22,609,000	$-25,800,000
Cash Flow From Continuing Operating Activities	$-38,207,000	$-23,453,000	$-22,609,000	$-25,800,000
Operating Gains Losses	-	-	$232,000	$275,000
Investing Activities
Capital Expenditure	$-242,000	-	-	-
Investing Cash Flow	$-242,000	$0	-	$0
Cash Flow From Continuing Investing Activities	$-242,000	$0	-	$0
Financing Activities
Issuance Of Capital Stock	$42,436,000	$62,106,000	$0	-
Financing Cash Flow	$41,138,000	$54,696,000	$1,756,000	$7,031,000
Cash Flow From Continuing Financing Activities	$41,138,000	$54,696,000	$1,756,000	$7,031,000
Net Other Financing Charges	$-1,016,000	$-4,895,000	-	$-149,000
Net Common Stock Issuance	$42,436,000	$62,106,000	$0	-
Common Stock Issuance	$42,436,000	$62,106,000	$0	-
Other
Repayment Of Debt	$-290,000	$-2,560,000	$-912,000	$-356,000
End Cash Position	$59,723,000	$54,912,000	$26,213,000	$46,517,000
Beginning Cash Position	$54,912,000	$26,213,000	$46,517,000	$67,152,000
Effect Of Exchange Rate Changes	$2,122,000	$-2,544,000	$549,000	$-1,866,000
Changes In Cash	$2,689,000	$31,243,000	$-20,853,000	$-18,769,000
Proceeds From Stock Option Exercised	$8,000	$45,000	$2,668,000	$263,000
Net Issuance Payments Of Debt	$-290,000	$-2,560,000	$-912,000	$6,917,000
Net Long Term Debt Issuance	$-290,000	$-2,560,000	$-912,000	$6,917,000
Long Term Debt Payments	$-290,000	$-2,560,000	$-912,000	$-356,000
Net Intangibles Purchase And Sale	$-66,000	$0	-	$0
Purchase Of Intangibles	$-66,000	$0	-	$0
Net PPE Purchase And Sale	$-176,000	$0	-	$0
Purchase Of PPE	$-176,000	$0	-	$0
Change In Working Capital	$-1,713,000	$591,000	$540,000	$-5,629,000
Change In Other Working Capital	$397,000	$-1,097,000	$246,000	$-1,929,000
Change In Payables And Accrued Expense	$420,000	$815,000	$1,055,000	$-255,000
Change In Payable	$420,000	$815,000	$1,055,000	$-255,000
Change In Account Payable	$378,000	$815,000	$1,354,000	$-566,000
Change In Tax Payable	$42,000	$0	$-299,000	$311,000
Change In Income Tax Payable	$42,000	$0	$-299,000	$311,000
Change In Prepaid Assets	$464,000	$31,000	$-158,000	$-157,000
Change In Inventory	$-2,822,000	$656,000	$353,000	$-1,864,000
Change In Receivables	$-172,000	$186,000	$-956,000	$-1,424,000
Other Non Cash Items	$26,000	$255,000	$828,000	$-143,000
Stock Based Compensation	$5,490,000	$2,581,000	$3,417,000	$4,238,000
Depreciation Amortization Depletion	$560,000	$936,000	$929,000	$1,604,000
Depreciation And Amortization	$560,000	$936,000	$929,000	$1,604,000
Amortization Cash Flow	$187,000	$229,000	$202,000	$704,000
Amortization Of Intangibles	$187,000	$229,000	$202,000	$704,000
Depreciation	$373,000	$707,000	$727,000	$900,000
Net Income From Continuing Operations	$-42,570,000	$-27,816,000	$-28,323,000	$-28,669,000
Issuance Of Debt	-	-	$0	$7,273,000
Interest Paid Supplemental Data	-	-	$669,000	$43,000
Income Tax Paid Supplemental Data	-	-	$160,000	$55,000
Long Term Debt Issuance	-	-	$0	$7,273,000
Asset Impairment Charge	-	-	$0	$2,524,000
Gain Loss On Investment Securities	-	-	$232,000	$275,000
Changes In Account Receivables	-	-	-	-

Fetched: 2026-06-17